Dendritic cells in melanoma immunotherapy

Mark B Faries1, Brian J Czerniecki

  • 1Department of Surgery, University of Pennsylvania, 4 Silverstein, 3400 Spruce St., Philadelphia, PA 19104, USA.

Insights

Dendritic cell vaccines show promise for melanoma treatment. Patients with advanced or adjuvant melanoma should consider investigating these investigational therapies.

Area of Science:

  • Oncology
  • Immunotherapy

Background:

  • Optimal systemic treatment for melanoma remains debated, particularly in adjuvant and metastatic settings.
  • Current treatment options lack universal consensus, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To explore the potential of dendritic cell (DC) vaccine therapy as a treatment strategy for melanoma.
  • To highlight the preliminary data supporting DC vaccine efficacy in melanoma patients.

Main Methods:

  • Review of investigational dendritic cell vaccine protocols for melanoma.
  • Analysis of preliminary clinical data from ongoing studies.

Main Results:

  • Dendritic cell vaccine therapy demonstrates promising preliminary results in melanoma treatment.
  • The investigational approach warrants further exploration in clinical settings.

Conclusions:

  • Dendritic cell vaccines represent a promising avenue for melanoma management.
  • Patients with metastatic or adjuvant melanoma should consider evaluating open clinical trials involving DC vaccine strategies.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...